Health Care & Life Sciences » Biotechnology | Sirona Biochem Corp.

Sirona Biochem Corp. | Balance Sheet

Fiscal year is November-October. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
926.30
613.40
1,552.90
623.10
282.90
339.80
Total Accounts Receivable
480.60
575.70
491.90
406.50
937.40
303.60
Other Current Assets
31.70
63.70
376.40
102.40
30.80
127.10
Total Current Assets
1,438.60
1,252.70
2,421.30
1,132.00
1,251.00
770.50
Net Property, Plant & Equipment
43.00
33.10
29.20
278.10
-
-
Intangible Assets
2,005.70
2,142.10
1,697.00
1,715.00
-
-
Total Assets
3,487.40
3,428.00
4,147.50
3,125.00
1,251.00
770.50
ST Debt & Current Portion LT Debt
506.20
9.30
669.00
33.80
732.70
Accounts Payable
279.90
388.20
166.20
189.30
310.90
Other Current Liabilities
7.30
125.70
368.00
319.60
209.50
Total Current Liabilities
793.40
523.20
1,203.20
542.60
1,253.10
Long-Term Debt
9.30
664.30
733.80
934.80
1,985.60
Provision for Risks & Charges
15.30
56.20
69.90
84.40
83.60
Deferred Taxes
430.00
394.00
-
-
-
Total Liabilities
1,248.10
1,637.70
2,006.90
1,561.90
3,322.30
Common Equity (Total)
2,239.30
1,790.30
2,140.50
1,563.20
2,071.30
Total Shareholders' Equity
2,239.30
1,790.30
2,140.50
1,563.20
2,071.30
Total Equity
2,239.30
1,790.30
2,140.50
1,563.20
2,071.30
Liabilities & Shareholders' Equity
3,487.40
3,428.00
4,147.50
3,125.00
1,251.00

About Sirona Biochem

View Profile
Address
595 Burrard Street
Vancouver British Columbia V7X 1L3
Canada
Employees -
Website http://www.sironabiochem.com
Updated 07/08/2019
Sirona Biochem Corp. engages in the development of diabetes therapeutics, skin depigmenting, and anti-aging agents for cosmetic use, biological ingredients, and cancer vaccine antigens. It also involves in utilizing a proprietary chemistry technique to improve pharmaceutical properties of carbohydrate-based molecules. The company was founded by Howard Jarman Verrico on October 19, 2006 and is headquartered in Vancouver, Canada.